Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

dti announces nominees for 2008 Science and Technology Awards
2008-10-03

 

At the announcement of the nominees for the 2008 dti Technology Awards were, from the left: Prof. Schalk Louw, Department of Zoology and Entomology, Mr Sipho Zikode, Deputy Director General at the Department of Trade and Industry (dti), Dr Romilla Maharaj, Executive Director: Human and Institutional Capacity Development at the National Research Foundation (NRF), and Mr Ephraim Baloyi, Director: Innovation and Technology at the dti.

Mr Michael Chung, master’s student in Plant Pathology, explaining some of the research conducted in the Centre for Plant Health Management (Cephma).

Prof. Schalk Louw, Department of Zoology and Entomology, and Mr Ephraim Baloyi, Director: Innovation and Technology at the dti in the Cephma laboratory.

   
dti announces nominees for 2008 Science and Technology Awards

The Department of Trade and Industry’s (dti) Deputy Director-General, Mr Sipho Zikode, yesterday announced the nominees for the 2008 dti Technology Awards which will take place on 30 and 31 October in Bloemfontein.

The purpose of these annual awards is to recognise those researchers, private institutions and students who performed well in terms of innovation and technology development, says Mr Ephraim Baloyi, Director: Innovation and Technology at the dti.

The awards are a combination of the Annual Awards of the different dti programmes supporting technology in industry. They are the Technology and Human Resources for Industry Programme (THRIP), administered by the National Research Foundation (NRF), the Support Programme for Industrial Innovation (SPII), administered by the Industrial Development Corporation, and seda Technology Programme (stp), administered by the Small Enterprise Development Agency.

The dti delegation also visited the laboratory of Prof. Schalk Louw of the UFS to view the work of this former dti Technology Awards recipient. Prof. Louw is a member of the UFS Centre for Plant Health Management (Cephma) team that won a 2007 Technology Award for groundbreaking research work on kenaf (a South African commercial fibre crop used, amongst others, in the automotive industry). The research of the Cephma team is supported by the NRF’s THRIP programme.

The awards are hosted in a different province each year to increase awareness around the dti’s technology support for researchers, small enterprises, large industries and business incubators.

Media Release
Issued by: Leonie Bolleurs
Tel: 051 401 2707
Cell: 083 645 5853
3 October 2008

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept